Literature DB >> 10747789

Histidine 295 and histidine 510 are crucial for the enzymatic degradation of heparan sulfate by heparinase III.

K Pojasek1, Z Shriver, Y Hu, R Sasisekharan.   

Abstract

The heparinases from Flavobacterium heparinum are powerful tools in understanding how heparin-like glycosaminoglycans function biologically. Heparinase III is the unique member of the heparinase family of heparin-degrading lyases that recognizes the ubiquitous cell-surface heparan sulfate proteoglycans as its primary substrate. Given that both heparinase I and heparinase II contain catalytically critical histidines, we examined the role of histidine in heparinase III. Through a series of diethyl pyrocarbonate modification experiments, it was found that surface-exposed histidines are modified in a concentration-dependent fashion and that this modification results in inactivation of the enzyme (k(inact) = 0.20 +/- 0.04 min(-)(1) mM(-)(1)). The DEPC modification was pH dependent and reversible by hydroxylamine, indicating that histidines are the sole residue being modified. As previously observed for heparinases I and II, substrate protection experiments slowed the inactivation kinetics, suggesting that the modified residue(s) was (were) in or proximal to the active site of the enzyme. Proteolytic mapping experiments, taken together with site-directed mutagenesis studies, confirm the chemical modification experiments and point to two histidines, histidine 295 and histidine 510, as being essential for heparinase III enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747789     DOI: 10.1021/bi992514k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Stimulatory action of internal protons on Slo1 BK channels.

Authors:  Vladimir Avdonin; Xiang Dong Tang; Toshinori Hoshi
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

2.  Lung heparan sulfates modulate K(fc) during increased vascular pressure: evidence for glycocalyx-mediated mechanotransduction.

Authors:  Randal O Dull; Mark Cluff; Joseph Kingston; Denzil Hill; Haiyan Chen; Soeren Hoehne; Daniel T Malleske; Rajwinederjit Kaur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-09       Impact factor: 5.464

3.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis.

Authors:  Dongfang Liu; Zachary Shriver; Ganesh Venkataraman; Yosuf El Shabrawi; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination.

Authors:  Udayanath Aich; Zachary Shriver; Kannan Tharakaraman; Rahul Raman; Ram Sasisekharan
Journal:  Anal Chem       Date:  2011-09-19       Impact factor: 6.986

Review 5.  Targeting heparin and heparan sulfate protein interactions.

Authors:  Ryan J Weiss; Jeffrey D Esko; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2017-06-27       Impact factor: 3.876

6.  The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanism.

Authors:  James E Thompson; Meraj Pourhossein; Amy Waterhouse; Thomas Hudson; Marie Goldrick; Jeremy P Derrick; Ian S Roberts
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

7.  The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.

Authors:  Yang Yang; Veronica MacLeod; Yuemeng Dai; Yekaterina Khotskaya-Sample; Zachary Shriver; Ganesh Venkataraman; Ram Sasisekharan; Annamaria Naggi; Giangiacomo Torri; Benito Casu; Israel Vlodavsky; Larry J Suva; Joshua Epstein; Shmuel Yaccoby; John D Shaughnessy; Bart Barlogie; Ralph D Sanderson
Journal:  Blood       Date:  2007-05-29       Impact factor: 22.113

8.  Rational design of low-molecular weight heparins with improved in vivo activity.

Authors:  Mallik Sundaram; Yiwei Qi; Zachary Shriver; Dongfang Liu; Ganlin Zhao; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

9.  An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure.

Authors:  Daniela Beccati; Miroslaw Lech; Jennifer Ozug; Nur Sibel Gunay; Jing Wang; Elaine Y Sun; Joël R Pradines; Victor Farutin; Zachary Shriver; Ganesh V Kaundinya; Ishan Capila
Journal:  Glycoconj J       Date:  2016-10-22       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.